Close menu




January 14th, 2022 | 10:13 CET

TeamViewer, Meta Materials, Deutsche Bank: Do your research and beat the market

  • Technology
Photo credits: pixabay.com

Sometimes the technology that everyone has known for years becomes a game changer overnight. That is what happened at the beginning of the pandemic with the TeamViewer software. Sometimes things turn out differently, and innovations are so revolutionary that it takes a while for the market to recognize the potential. We examine three stocks for their innovation potential and explain whether or not the market understands the equity stories.

time to read: 3 minutes | Author: Nico Popp
ISIN: TEAMVIEWER AG INH O.N. | DE000A2YN900 , Meta Materials Inc. | US59134N1046 , DEUTSCHE BANK AG NA O.N. | DE0005140008

Table of contents:


    TeamViewer: Where is the journey heading?

    TeamViewer's stock recently posted significant gains. The reason: The figures turned out somewhat better than expected. The MDAX-listed group saved and therefore earned a little more as a result. However, there were no notable bright spots recently regarding actual orders. The Company is still trading on the stock market, more than 50% below the level of the first pandemic weeks. This example shows that the hype surrounding certain technologies often fades faster than expected - after all, the home office is currently experiencing a boom again.

    Nevertheless, there is a lot of fantasy surrounding the TeamViewer share. One reason for this may be the considerations that the portal researchanalyst.com made about TeamViewer at the end of November. At that time, the portal wrote: "On the other hand, TeamViewer, with a market capitalization of just EUR 2.45 billion, with a more than solid base technology and peppered with future technologies, could be an interesting purchase candidate. Since the Goeppingen-based Company is already cooperating with the software giant from Walldorf, a takeover by SAP, including a stay in Germany, would be obvious. Such technology is currently still missing from the major corporation's portfolio." A risk for TeamViewer, on the other hand, is the presumably highly remunerated sponsoring contract with Manchester United. It could reduce margins during the term of the agreement. Given the recent share price performance, the stock must be considered a comeback candidate. However, the value is not a sure-fire winner.

    Meta Materials: Anything between EUR 2 and EUR 20 is possible

    The Meta Materials share could also use a comeback: The stock is currently trading around EUR 2 - in June, it was EUR 20. The fact that the share is such a volatile plaything of speculators is also due to the business field of Meta Materials. The Nasdaq-listed company specializes in bringing so-called metamaterials to market maturity. These ultra-thin surfaces exhibit physical properties that do not exist in nature. These relate, for example, to optics or conductive properties. For example, a vehicle coated with metamaterials can refract light to flow around the vehicle, making it invisible. It sounds like science fiction, but the magazine Spektrum der Wissenschaft has devoted an entire topic page to it.

    Meta Materials states that it wants to realize a wide range of applications, such as transparent antennas in window panes and innovative head-up displays. The cost of producing the material is expected to drop significantly - investors specializing in innovations can take a closer look at the background. On February 17, Meta-Materials CEO George Palikaras will present online at the International Investment Forum (IIF) at 8:30 p.m. and then take questions from the audience. Before Meta Materials, numerous growth companies are presenting online for free. Meta Materials' stock has come down sharply. However, the topic has great potential. To dive deeper, growth investors need to form their own opinion.

    Deutsche Bank: Investments are lacking

    In order to profit from future growth, bank shares were long considered a solid alternative. Banks finance the economic success of tomorrow and thus earn a little. That was the assumption. Sometimes banks also participate in innovative business models. Deutsche Bank is following this path and securing a portion of the future in this way - but only since 2016. In 2020, media reports made the rounds according to which the due diligence alone for a seven-figure investment took 1.5 years. While Deutsche Bank took a close look at its investments, other investors pressed the pace. Even Commerzbank left its rival behind, treating itself to two venture capital subsidiaries at once. So is Deutsche Bank a lame duck?

    The once-proud bank may have been a bit stingy with fintech investments in the past, but the cost-cutting measures paid off at the end of 2021 when two rating agencies upgraded Deutsche Bank, which should benefit the blue bank's bread-and-butter business. Although this business is still some way from major innovations, the current consolidation is likely to be just the thing for long-suffering shareholders. The share is back in solid waters. Sometimes it doesn't have to be the big innovations.


    While Deutsche Bank's fundamentals are sound but growth is lacking, TeamViewer's shares thrive on the takeover fantasy. Such a situation can carry second-line stocks upwards for a long time and provide returns. However, investors must be prepared for surprises. There can also be surprises at Meta Materials - in both directions. Those who understand the technology may be able to get ahead of the market. The Company's potential appears great, provided everything works out. The IIF on February 17 should shed more light on the matter.


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may hold shares or other financial instruments of the aforementioned companies in the future or may bet on rising or falling prices and thus a conflict of interest may arise in the future. The Relevant Persons reserve the right to buy or sell shares or other financial instruments of the Company at any time (hereinafter each a "Transaction"). Transactions may, under certain circumstances, influence the respective price of the shares or other financial instruments of the Company.

    In addition, Apaton Finance GmbH is active in the context of the preparation and publication of the reporting in paid contractual relationships.

    For this reason, there is a concrete conflict of interest.

    The above information on existing conflicts of interest applies to all types and forms of publication used by Apaton Finance GmbH for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and the like on news.financial. These contents are exclusively for the information of the readers and do not represent any call to action or recommendations, neither explicitly nor implicitly they are to be understood as an assurance of possible price developments. The contents do not replace individual expert investment advice and do not constitute an offer to sell the discussed share(s) or other financial instruments, nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but a journalistic or advertising text. Readers or users who make investment decisions or carry out transactions on the basis of the information provided here do so entirely at their own risk. No contractual relationship is established between Apaton Finance GmbH and its readers or the users of its offers, as our information only refers to the company and not to the investment decision of the reader or user.

    The acquisition of financial instruments involves high risks, which can lead to the total loss of the invested capital. The information published by Apaton Finance GmbH and its authors is based on careful research. Nevertheless, no liability is assumed for financial losses or a content-related guarantee for the topicality, correctness, appropriateness and completeness of the content provided here. Please also note our Terms of use.


    Der Autor

    Nico Popp

    At home in Southern Germany, the passionate stock exchange expert has been accompanying the capital markets for about twenty years. With a soft spot for smaller companies, he is constantly on the lookout for exciting investment stories.

    About the author



    Related comments:

    Commented by Juliane Zielonka on September 30th, 2022 | 10:59 CEST

    Biogen, XPhyto, BioNTech: Alzheimer's disease, depression, cancer - Pharma for life

    • Biotechnology
    • Pharma
    • Investments
    • Technology

    About 350 million people worldwide are affected by depression, a disorder of the brain. Each person also has a 16 to 20% chance of becoming depressed. Reason enough for the Canadian Company XPhyto Therapeutics to research a drug that is not addictive and can defeat the mental health-related medical condition. This week, Biogen, among others, achieved a breakthrough with an active substance against Alzheimer's disease. And if you follow the Bundesliga closely, you may be aware of the cases of testicular cancer among the players. Now BioNTech senses a new opportunity...

    Read

    Commented by Fabian Lorenz on September 29th, 2022 | 13:17 CEST

    Up to 200% share price potential: Kion, BioNTech, Aspermont in analyst check

    • Technology
    • Biotechnology
    • Investments

    The profit warning was a shock for Kion shareholders. Accordingly, the share price halved to EUR 20 in September alone. Now analysts are also slashing their estimates. The price targets for the forklift manufacturer are falling accordingly. Berenberg surprises with a high price target for the BioNTech share. At the same time, the analysts emphasize their hope for a continued generous dividend. Shareholders could thus be kept in good spirits until the next blockbuster. The roadshow of Aspermont in Germany has probably also created a good mood. At least the share price has jumped. The current consolidation could be an entry opportunity. Analysts see a price potential of over 200%.

    Read

    Commented by Carsten Mainitz on September 29th, 2022 | 12:01 CEST

    Verbio, Kleos Space, KWS Saat - This news is moving share prices!

    • Space
    • Technology
    • Investments

    Increased uncertainties in geopolitics, rampant inflation with exploding commodity and energy prices, and higher interest rates are making it increasingly difficult for companies to meet the forecasts they issued at the beginning of the year. Recent examples include battery manufacturer Varta and real estate financier Hypoport, which had to withdraw their annual targets. In addition, however, a number of companies have been able to surprise on the upside despite all the challenges.

    Read